Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Randomisee Dans Les Adenocarcinomes Metastatiques Du Pancreas: Gemox Et Gemox Simplifie. [GEMOX]

NCT00268411 is registered in ClinicalTrials.gov with GERCOR - Multidisciplinary Oncology Cooperative Group as lead sponsor.

NCT NCT00268411
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00268411 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Randomisee Dans Les Adenocarcinomes Metastatiques Du Pancreas: Gemox Et Gemox Simplifie. [GEMOX]
Lead sponsor
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase
Phase 3
Overall status
Unknown status
Start date
September 30, 2004
Completion date
Not reported
Enrollment
80 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer